LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 15

Search options

  1. Article ; Online: Soluble Biomarkers of Cerebrovascular Pathologies.

    Foley, Kate E / Wilcock, Donna M

    Stroke

    2024  Volume 55, Issue 4, Page(s) 801–811

    Abstract: Vascular contributions to cognitive impairment and dementia (VCID) is an all-encompassing term that describes cognitive impairment due to cerebrovascular origins. With the advancement of imaging and pathological studies, we now understand that VCID is ... ...

    Abstract Vascular contributions to cognitive impairment and dementia (VCID) is an all-encompassing term that describes cognitive impairment due to cerebrovascular origins. With the advancement of imaging and pathological studies, we now understand that VCID is often comorbid with Alzheimer disease. While researchers in the Alzheimer disease field have been working for years to establish and test blood-based biomarkers for Alzheimer disease diagnosis, prognosis, clinical therapy discovery, and early detection, blood-based biomarkers for VCID are in their infancy and also face challenges. VCID is heterogeneous, comprising many different pathological entities (ischemic, or hemorrhagic), and spatial and temporal differences (acute or chronic). This review highlights pathways that are aiding the search for sensitive and specific blood-based cerebrovascular dysfunction markers, describes promising candidates, and explains ongoing initiatives to discover blood-based VCID biomarkers.
    MeSH term(s) Humans ; Alzheimer Disease/diagnosis ; Dementia, Vascular/diagnosis ; Cognitive Dysfunction ; Biomarkers/metabolism
    Chemical Substances Biomarkers
    Language English
    Publishing date 2024-03-25
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80381-9
    ISSN 1524-4628 ; 0039-2499 ; 0749-7954
    ISSN (online) 1524-4628
    ISSN 0039-2499 ; 0749-7954
    DOI 10.1161/STROKEAHA.123.044172
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Vascular Considerations for Amyloid Immunotherapy.

    Foley, Kate E / Wilcock, Donna M

    Current neurology and neuroscience reports

    2022  Volume 22, Issue 11, Page(s) 709–719

    Abstract: Purpose of review: Amyloid beta (Aβ) plaque accumulation is a hallmark pathology contributing to Alzheimer's disease (AD) and is widely hypothesized to lead to cognitive decline. Decades of research into anti-Aβ immunotherapies provide evidence for ... ...

    Abstract Purpose of review: Amyloid beta (Aβ) plaque accumulation is a hallmark pathology contributing to Alzheimer's disease (AD) and is widely hypothesized to lead to cognitive decline. Decades of research into anti-Aβ immunotherapies provide evidence for increased Aβ clearance from the brain; however, this is frequently accompanied by complicated vascular deficits. This article reviews the history of anti-Aβ immunotherapies and clinical findings and provides recommendations moving forward.
    Recent findings: In 20 years of both animal and human studies, anti-Aβ immunotherapies have been a prevalent avenue of reducing hallmark Aβ plaques. In both models and with different anti-Aβ antibody designs, amyloid-related imaging abnormalities (ARIA) indicating severe cerebrovascular compromise have been common and concerning occurrence. ARIA caused by anti-Aβ immunotherapy has been noted since the early 2000s, and the mechanisms driving it are still unknown. Recent approval of aducanumab comes with renewed urgency to consider vascular deficits caused by anti-Aβ immunotherapy.
    MeSH term(s) Animals ; Humans ; Amyloid beta-Peptides ; Plaque, Amyloid/drug therapy ; Plaque, Amyloid/pathology ; Alzheimer Disease/drug therapy ; Amyloidogenic Proteins ; Amyloid ; Immunotherapy/methods ; Immunologic Factors ; Disease Models, Animal
    Chemical Substances Amyloid beta-Peptides ; Amyloidogenic Proteins ; Amyloid ; Immunologic Factors
    Language English
    Publishing date 2022-10-21
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2057363-7
    ISSN 1534-6293 ; 1528-4042
    ISSN (online) 1534-6293
    ISSN 1528-4042
    DOI 10.1007/s11910-022-01235-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Mechanisms of ARIA: is it time to focus on the unique immune environment of the neurovascular unit?

    Foley, Kate E / Weekman, Erica M / Wilcock, Donna M

    Molecular neurodegeneration

    2023  Volume 18, Issue 1, Page(s) 76

    MeSH term(s) Humans ; Brain ; Cerebral Amyloid Angiopathy ; Alzheimer Disease ; Blood-Brain Barrier
    Language English
    Publishing date 2023-10-20
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2244557-2
    ISSN 1750-1326 ; 1750-1326
    ISSN (online) 1750-1326
    ISSN 1750-1326
    DOI 10.1186/s13024-023-00667-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Assessment of Neurovascular Uncoupling:

    Onos, Kristen / Lin, Peter B / Pandey, Ravi S / Persohn, Scott A / Burton, Charles P / Miner, Ethan W / Eldridge, Kierra / Kanyinda, Jonathan Nyandu / Foley, Kate E / Carter, Gregory W / Howell, Gareth R / Territo, Paul R

    bioRxiv : the preprint server for biology

    2024  

    Abstract: Background: Alzheimer's disease (AD) is the most common cause of dementia worldwide, with apolipoprotein ε4 (: Methods: PET imaging was used to assess metabolism-perfusion in both sexes of aging C57BL/6J, and h: Results: All h: Discussion: This ...

    Abstract Background: Alzheimer's disease (AD) is the most common cause of dementia worldwide, with apolipoprotein ε4 (
    Methods: PET imaging was used to assess metabolism-perfusion in both sexes of aging C57BL/6J, and h
    Results: All h
    Discussion: This work highlights
    Language English
    Publishing date 2024-03-13
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.12.13.571584
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction.

    Onos, Kristen D / Lin, Peter B / Pandey, Ravi S / Persohn, Scott A / Burton, Charles P / Miner, Ethan W / Eldridge, Kierra / Kanyinda, Jonathan Nyandu / Foley, Kate E / Carter, Gregory W / Howell, Gareth R / Territo, Paul R

    Alzheimer's & dementia : the journal of the Alzheimer's Association

    2024  

    Abstract: Background: Alzheimer's disease (AD) is the most common cause of dementia worldwide, with apolipoprotein Eε4 (APOEε4) being the strongest genetic risk factor. Current clinical diagnostic imaging focuses on amyloid and tau; however, new methods are ... ...

    Abstract Background: Alzheimer's disease (AD) is the most common cause of dementia worldwide, with apolipoprotein Eε4 (APOEε4) being the strongest genetic risk factor. Current clinical diagnostic imaging focuses on amyloid and tau; however, new methods are needed for earlier detection.
    Methods: PET imaging was used to assess metabolism-perfusion in both sexes of aging C57BL/6J, and hAPOE mice, and were verified by transcriptomics, and immunopathology.
    Results: All hAPOE strains showed AD phenotype progression by 8 months, with females exhibiting the regional changes, which correlated with GO-term enrichments for glucose metabolism, perfusion, and immunity. Uncoupling analysis revealed APOEε4/ε4 exhibited significant Type-1 uncoupling (↓ glucose uptake, ↑ perfusion) at 8 and 12 months, while APOEε3/ε4 demonstrated Type-2 uncoupling (↑ glucose uptake, ↓ perfusion), while immunopathology confirmed cell specific contributions.
    Discussion: This work highlights APOEε4 status in AD progression manifests as neurovascular uncoupling driven by immunological activation, and may serve as an early diagnostic biomarker.
    Highlights: We developed a novel analytical method to analyze PET imaging of
    Language English
    Publishing date 2024-05-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2211627-8
    ISSN 1552-5279 ; 1552-5260
    ISSN (online) 1552-5279
    ISSN 1552-5260
    DOI 10.1002/alz.13842
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: APOE

    Foley, Kate E / Diemler, Cory A / Hewes, Amanda A / Garceau, Dylan T / Sasner, Michael / Howell, Gareth R

    Alzheimer's & dementia (New York, N. Y.)

    2022  Volume 8, Issue 1, Page(s) e12308

    Abstract: Introduction: Apolipoprotein E (: Methods: To address this, male and female : Results: Data revealed chronic running decreased age-dependent weight gain, lean and fat mass, and serum low-density lipoprotein concentration dependent on : ... ...

    Abstract Introduction: Apolipoprotein E (
    Methods: To address this, male and female
    Results: Data revealed chronic running decreased age-dependent weight gain, lean and fat mass, and serum low-density lipoprotein concentration dependent on
    Discussion: These data in humanized mouse models provide compelling evidence that
    Language English
    Publishing date 2022-06-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2832891-7
    ISSN 2352-8737 ; 2352-8737
    ISSN (online) 2352-8737
    ISSN 2352-8737
    DOI 10.1002/trc2.12308
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: The

    Foley, Kate E / Hewes, Amanda A / Garceau, Dylan T / Kotredes, Kevin P / Carter, Gregory W / Sasner, Michael / Howell, Gareth R

    Frontiers in aging neuroscience

    2022  Volume 14, Page(s) 838436

    Abstract: Introduction: Restrictions on existing : Methods: As a part of MODEL-AD, we created and validated new versions of humanized : Results: Expression of human APOE isoforms were confirmed in : Discussion: ... ...

    Abstract Introduction: Restrictions on existing
    Methods: As a part of MODEL-AD, we created and validated new versions of humanized
    Results: Expression of human APOE isoforms were confirmed in
    Discussion: APOE
    Language English
    Publishing date 2022-03-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2558898-9
    ISSN 1663-4365
    ISSN 1663-4365
    DOI 10.3389/fnagi.2022.838436
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Transcriptional profiling predicts running promotes cerebrovascular remodeling in young but not midlife mice.

    Foley, Kate E / Yang, Hongtian Stanley / Graham, Leah C / Howell, Gareth R

    BMC genomics

    2019  Volume 20, Issue 1, Page(s) 860

    Abstract: Background: The incidence of dementia and cognitive decline is increasing with no therapy or cure. One of the reasons treatment remains elusive is because there are various pathologies that contribute to age-related cognitive decline. Specifically, with ...

    Abstract Background: The incidence of dementia and cognitive decline is increasing with no therapy or cure. One of the reasons treatment remains elusive is because there are various pathologies that contribute to age-related cognitive decline. Specifically, with Alzheimer's disease, targeting to reduce amyloid beta plaques and phosphorylated tau aggregates in clinical trials has not yielded results to slow symptomology, suggesting a new approach is needed. Interestingly, exercise has been proposed as a potential therapeutic intervention to improve brain health and reduce the risk for dementia, however the benefits throughout aging are not well understood.
    Results: To better understand the effects of exercise, we preformed transcriptional profiling on young (1-2 months) and midlife (12 months) C57BL/6 J (B6) male mice after 12 weeks of voluntary running. Data was compared to age-matched sedentary controls. Interestingly, the midlife running group naturally broke into two cohorts based on distance ran - either running a lot and more intensely (high runners) or running less and less intensely (low runners). Midlife high runners had lower LDL cholesterol as well as lower adiposity (%fat) compared to sedentary, than midlife low runners compared to sedentary suggesting more intense running lowered systemic markers of risk for age-related diseases including dementias. Differential gene analysis of transcriptional profiles generated from the cortex and hippocampus showed thousands of differentially expressed (DE) genes when comparing young runners to sedentary controls. However, only a few hundred genes were DE comparing either midlife high runners or midlife low runners to midlife sedentary controls. This indicates that, in our study, the effects of running are reduced through aging. Gene set enrichment analyses identified enrichment of genes involved in extracellular matrix (ECM), vascular remodeling and angiogenesis in young runners but not midlife runners. These genes are known to be expressed in multiple vascular-related cell types including astrocytes, endothelial cells, pericytes and smooth muscle cells.
    Conclusions: Taken together these results suggest running may best serve as a preventative measure to reduce risk for cerebrovascular decline. Ultimately, this work shows that exercise may be more effective to prevent dementia if introduced at younger ages.
    MeSH term(s) Age Factors ; Animals ; Cerebral Cortex/blood supply ; Cerebral Cortex/metabolism ; Cerebrovascular Circulation ; Computational Biology/methods ; Extracellular Matrix/genetics ; Extracellular Matrix/metabolism ; Gene Expression Profiling ; Gene Expression Regulation ; Gene Ontology ; Male ; Mice ; Models, Biological ; Organ Specificity/genetics ; Running ; Transcriptome ; Vascular Remodeling/genetics
    Language English
    Publishing date 2019-11-14
    Publishing country England
    Document type Journal Article
    ISSN 1471-2164
    ISSN (online) 1471-2164
    DOI 10.1186/s12864-019-6230-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Genetic basis of susceptibility to low‐dose paraquat and variation between the sexes in Drosophila melanogaster

    Lovejoy, Pamela C / Foley, Kate E / Conti, Melissa M / Meadows, Samantha M / Bishop, Christopher / Fiumera, Anthony C

    Molecular ecology. 2021 May, v. 30, no. 9

    2021  

    Abstract: Toxicant resistance is a complex trait, affected both by genetics and the environment. Like most complex traits, it can exhibit sexual dimorphism, yet sex is often overlooked as a factor in studies of toxicant resistance. Paraquat, one such toxicant, is ... ...

    Abstract Toxicant resistance is a complex trait, affected both by genetics and the environment. Like most complex traits, it can exhibit sexual dimorphism, yet sex is often overlooked as a factor in studies of toxicant resistance. Paraquat, one such toxicant, is a commonly used herbicide and is known to produce mitochondrial oxidative stress, decrease dopaminergic neurons and dopamine (DA) levels, and decrease motor ability. While the main effects of paraquat are well‐characterized, less is known about the naturally occurring variation in paraquat susceptibility. The purpose of this study was to map the genes contributing to low‐dose paraquat susceptibility in Drosophila melanogaster, and to determine if susceptibility differs between the sexes. One hundred of the Drosophila Genetic Reference Panel (DGRP) lines were scored for susceptibility via climbing ability and used in a genome‐wide association study (GWAS). Variation in seventeen genes in females and thirty‐five genes in males associated with paraquat susceptibility. Only two candidate genes overlapped between the sexes despite a significant positive correlation between male and female susceptibilities. Many associated polymorphisms had significant interactions with sex, with most having conditionally neutral effects. Conditional neutrality between the sexes probably stems from sex‐biased expression which may result from partial resolution of sexual conflict. Candidate genes were verified with RNAi knockdowns, gene expression analyses, and DA quantification. Several of these genes are novel associations with paraquat susceptibility. This research highlights the importance of assessing both sexes when studying toxicant susceptibility.
    Keywords Drosophila melanogaster ; dopamine ; ecology ; females ; gene expression ; genome-wide association study ; males ; mitochondria ; oxidative stress ; paraquat ; sexual dimorphism
    Language English
    Dates of publication 2021-05
    Size p. 2040-2053.
    Publishing place John Wiley & Sons, Ltd
    Document type Article
    Note NAL-AP-2-clean ; JOURNAL ARTICLE
    ZDB-ID 1126687-9
    ISSN 1365-294X ; 0962-1083
    ISSN (online) 1365-294X
    ISSN 0962-1083
    DOI 10.1111/mec.15878
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort.

    Foley, Kate E / Winder, Zachary / Sudduth, Tiffany L / Martin, Barbara J / Nelson, Peter T / Jicha, Gregory A / Harp, Jordan P / Weekman, Erica M / Wilcock, Donna M

    Alzheimer's & dementia : the journal of the Alzheimer's Association

    2023  Volume 20, Issue 2, Page(s) 1374–1386

    Abstract: Introduction: Protein-based plasma assays provide hope for improving accessibility and specificity of molecular diagnostics to diagnose dementia.: Methods: Plasma was obtained from participants (N = 837) in our community-based University of Kentucky ... ...

    Abstract Introduction: Protein-based plasma assays provide hope for improving accessibility and specificity of molecular diagnostics to diagnose dementia.
    Methods: Plasma was obtained from participants (N = 837) in our community-based University of Kentucky Alzheimer's Disease Research Center cohort. We evaluated six Alzheimer's disease (AD)- and neurodegeneration-related (Aβ40, Aβ42, Aβ42/40, p-tau181, total tau, and NfLight) and five inflammatory biomarkers (TNF, IL6, IL8, IL10, and GFAP) using the SIMOA-based protein assay platform. Statistics were performed to assess correlations.
    Results: Our large cohort reflects previous plasma biomarker findings. Relationships between biomarkers to understand AD-inflammatory biomarker correlations showed significant associations between AD and inflammatory biomarkers suggesting peripheral inflammatory interactions with increasing AD pathology. Biomarker associations parsed out by clinical diagnosis (normal, MCI, and dementia) reveal changes in strength of the correlations across the cognitive continuum.
    Discussion: Unique AD-inflammatory biomarker correlations in a community-based cohort reveal a new avenue for utilizing plasma-based biomarkers in the assessment of AD and related dementias.
    Highlights: Large community cohorts studying sex, age, and APOE genotype effects on biomarkers are few. It is unknown how biomarker-biomarker associations vary through aging and dementia. Six AD (Aβ40, Aβ42, Aβ42/40, p-tau181, total tau, and NfLight) and five inflammatory biomarkers (TNFα, IL6, IL8, IL10, and GFAP) were used to examine associations between biomarkers. Plasma biomarkers suggesting increasing cerebral AD pathology corresponded to increases in peripheral inflammatory markers, both pro-inflammatory and anti-inflammatory. Strength of correlations, between pairs of classic AD and inflammatory plasma biomarker, changes throughout cognitive progression to dementia.
    MeSH term(s) Humans ; Alzheimer Disease/pathology ; Amyloid beta-Peptides ; Interleukin-10 ; Interleukin-6 ; Interleukin-8 ; tau Proteins ; Biomarkers ; United Kingdom ; Cognitive Dysfunction
    Chemical Substances Amyloid beta-Peptides ; Interleukin-10 (130068-27-8) ; Interleukin-6 ; Interleukin-8 ; tau Proteins ; Biomarkers
    Language English
    Publishing date 2023-11-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2211627-8
    ISSN 1552-5279 ; 1552-5260
    ISSN (online) 1552-5279
    ISSN 1552-5260
    DOI 10.1002/alz.13485
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top